328 related articles for article (PubMed ID: 21859738)
21. Angioimmunoblastic T-cell lymphoma (angioimmunoblastic lymphadenopathy with dysproteinemia [AILD]-type T-cell lymphoma) followed by Hodgkin's disease associated with Epstein-Barr virus.
Nakamura S; Sasajima Y; Koshikawa T; Kitoh K; Koike K; Motoori T; Ueda R; Mori S; Suchi T
Pathol Int; 1995 Dec; 45(12):958-64. PubMed ID: 8808302
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkin's lymphoma: a clinicopathologic study.
Asano N; Oshiro A; Matsuo K; Kagami Y; Ishida F; Suzuki R; Kinoshita T; Shimoyama Y; Tamaru J; Yoshino T; Kitamura K; Fukutani H; Morishima Y; Nakamura S
J Clin Oncol; 2006 Oct; 24(28):4626-33. PubMed ID: 16954517
[TBL] [Abstract][Full Text] [Related]
23. Leucocyte-specific protein (LSP1) in malignant lymphoma and Hodgkin's disease.
Marafioti T; Jabri L; Pulford K; Brousset P; Mason DY; Delsol G
Br J Haematol; 2003 Feb; 120(4):671-8. PubMed ID: 12588355
[TBL] [Abstract][Full Text] [Related]
24. CD20 positivity in classical Hodgkin's lymphoma: Diagnostic challenge or targeting opportunity.
Barakzai MA; Pervez S
Indian J Pathol Microbiol; 2009; 52(1):6-9. PubMed ID: 19136769
[TBL] [Abstract][Full Text] [Related]
25. Hodgkin's disease expressing follicular dendritic cell marker CD21 without any other B-cell marker: a clinicopathologic study of nine cases.
Nakamura S; Nagahama M; Kagami Y; Yatabe Y; Takeuchi T; Kojima M; Motoori T; Suzuki R; Taji H; Ogura M; Mizoguchi Y; Okamoto M; Suzuki H; Oyama A; Seto M; Morishima Y; Koshikawa T; Takahashi T; Kurita S; Suchi T
Am J Surg Pathol; 1999 Apr; 23(4):363-76. PubMed ID: 10199466
[TBL] [Abstract][Full Text] [Related]
26. Lymphocyte-rich classical Hodgkin's lymphoma: distinctive tumor and microenvironment markers.
Nam-Cha SH; Montes-Moreno S; Salcedo MT; Sanjuan J; Garcia JF; Piris MA
Mod Pathol; 2009 Aug; 22(8):1006-15. PubMed ID: 19465900
[TBL] [Abstract][Full Text] [Related]
27. Composite marginal zone B-cell lymphoma and classical Hodgkin's lymphoma: a clinicopathological study of 12 cases.
Zettl A; Rüdiger T; Marx A; Müller-Hermelink HK; Ott G
Histopathology; 2005 Feb; 46(2):217-28. PubMed ID: 15693895
[TBL] [Abstract][Full Text] [Related]
28. Analysis of transcription factor OCT.1, OCT.2 and BOB.1 expression using tissue arrays in classical Hodgkin's lymphoma.
García-Cosío M; Santón A; Martín P; Camarasa N; Montalbán C; García JF; Bellas C
Mod Pathol; 2004 Dec; 17(12):1531-8. PubMed ID: 15257313
[TBL] [Abstract][Full Text] [Related]
29. Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study.
Vandenberghe P; Wlodarska I; Tousseyn T; Dehaspe L; Dierickx D; Verheecke M; Uyttebroeck A; Bechter O; Delforge M; Vandecaveye V; Brison N; Verhoef GE; Legius E; Amant F; Vermeesch JR
Lancet Haematol; 2015 Feb; 2(2):e55-65. PubMed ID: 26687610
[TBL] [Abstract][Full Text] [Related]
30. Sequential development of Hodgkin's disease and CD30+ diffuse large B-cell lymphoma in a patient with MALT-type lymphoma: evidence of different clonal origin of single microdissected Reed-Sternberg cells.
Parrens M; Vergier B; Fitoussi O; Lahet C; Belleannee G; Marit G; Dubus P; de Mascarel A; Delfau-Larue MH; Merlio JP
Am J Surg Pathol; 2002 Dec; 26(12):1634-42. PubMed ID: 12459631
[TBL] [Abstract][Full Text] [Related]
31. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
Lim MS; Beaty M; Sorbara L; Cheng RZ; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2002 Nov; 26(11):1458-66. PubMed ID: 12409722
[TBL] [Abstract][Full Text] [Related]
32. Lymph node infarction in classical Hodgkin's lymphoma.
Mori E; Enomoto Y; Nakamine H; Kasai T; Takeda M; Takano M; Morita K; Koizumi T; Nonomura A
J Clin Exp Hematop; 2012; 52(1):35-9. PubMed ID: 22706529
[TBL] [Abstract][Full Text] [Related]
33. Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma.
Gonzalez CL; Medeiros LJ; Jaffe ES
Am J Clin Pathol; 1991 Jul; 96(1):81-9. PubMed ID: 2069139
[TBL] [Abstract][Full Text] [Related]
34. [Histopathological diagnosis of Hodgkin's disease].
Delsol G
Rev Prat; 1998 May; 48(10):1060-4. PubMed ID: 9781148
[TBL] [Abstract][Full Text] [Related]
35. Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules.
Foss HD; Anagnostopoulos I; Araujo I; Assaf C; Demel G; Kummer JA; Hummel M; Stein H
Blood; 1996 Nov; 88(10):4005-11. PubMed ID: 8916967
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus-associated extranodal non-Hodgkin's lymphoma of the sinonasal tract and nasopharynx in Thailand.
Mitarnun W; Suwiwat S; Pradutkanchana J
Asian Pac J Cancer Prev; 2006; 7(1):91-4. PubMed ID: 16629523
[TBL] [Abstract][Full Text] [Related]
37. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
[TBL] [Abstract][Full Text] [Related]
38. Pathology and "molecular histology' of Hodgkin's disease and the border to non-Hodgkin's lymphomas.
Hansmann ML; Küppers R
Baillieres Clin Haematol; 1996 Sep; 9(3):459-77. PubMed ID: 8922240
[TBL] [Abstract][Full Text] [Related]
39. Association of Hodgkin's lymphoma with Epstein Barr virus infection.
Cickusić E; Mustedanagić-Mujanović J; Iljazović E; Karasalihović Z; Skaljić I
Bosn J Basic Med Sci; 2007 Feb; 7(1):58-65. PubMed ID: 17489771
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus-positive nodal T/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features.
Jeon YK; Kim JH; Sung JY; Han JH; Ko YH;
Hum Pathol; 2015 Jul; 46(7):981-90. PubMed ID: 25907865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]